Why is pancreatic cancer the king of all cancers

Pancreatic cancer is known as the "king of all cancers" due to its unclear early symptoms, hidden location that makes surgery difficult, rapid early metastasis, poor response to treatment, and high recurrence rate. If symptoms persist, it is recommended to seek medical attention in a timely manner and take targeted treatment measures under the guidance of a doctor. The details are as follows:

1. Early symptoms are not obvious: Pancreatic cancer usually has no obvious symptoms in the early stage, and it is difficult to detect in the early stage. Early symptoms such as abdominal pain, indigestion, weight loss, etc. are often ignored, resulting in patients being diagnosed in the late stage.

Measures: In order to detect pancreatic cancer early, regular physical examinations are key, especially for high-risk groups who should undergo detailed abdominal ultrasound or CT examinations once a year. If there is a family history or a history of chronic pancreatitis, you should pay more attention to the health of your pancreas. At the same time, pay attention to any persistent abdominal discomfort and seek medical attention in time.

2. Hidden location and difficult for surgery: The pancreas is located deep in the abdominal cavity, surrounded by many important blood vessels and organs, making surgery difficult. Many patients are unable to undergo surgical treatment by the time of diagnosis.

Measures: In the early stage of diagnosis, detailed imaging examinations such as CT and MRI should be performed as soon as possible to determine the location and size of the tumor and assess the feasibility of surgery. For patients who are feasible for surgery, surgical resection should be arranged as soon as possible. For patients who are not suitable for surgery, other comprehensive treatment methods should be adopted.

3. Rapid early metastasis: Pancreatic cancer cells are easy to spread and metastasize, often with distant metastasis occurring in the early stages. Common metastatic sites include the liver, lungs, and peritoneum.

Measures: Combine surgery, radiotherapy, chemotherapy and other comprehensive treatment methods to control tumor spread. For patients with distant metastasis, chemotherapy drugs such as gemcitabine injection can be used. Patients must follow the doctor's instructions to use the drugs. Regular full-body examinations are performed to monitor metastasis.

4. Poor response to treatment: Pancreatic cancer has low sensitivity to conventional chemotherapy drugs and the treatment effect is poor. Many patients do not see obvious results during the treatment process.

Measures: Develop and apply new targeted therapeutic drugs, such as erlotinib tablets, and patients must use the drugs according to the doctor's instructions. At the same time, actively participate in clinical trials, explore new treatment methods, and find more effective drug combinations and treatment strategies.

5. High recurrence rate: Even after surgical resection, the recurrence rate of pancreatic cancer is still high, resulting in a low long-term survival rate. Patients after surgery need long-term follow-up and monitoring to detect recurrence in time.

Measures: Regular follow-up after surgery, regular imaging examinations and tumor marker tests should be performed to detect recurrence in a timely manner. Combined with radiotherapy, chemotherapy and immunotherapy, recurrence can be delayed as much as possible to improve the patient's quality of life and survival.

Pancreatic cancer is known as the "king of all cancers" and its lethality and complexity are daunting. Early screening, comprehensive treatment and regular follow-up are the keys to improving the survival rate of pancreatic cancer patients. I hope that every patient can actively treat the disease and maintain an optimistic attitude.